Elke Zwanziger
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
In vitro and clinical investigations to determine the drug-drug interaction potential of entrectinib, a small molecule inhibitor of neurotrophic tyrosine receptor kinase (NTRK).
Journal: Investigational new drugs
Published: April 15, 2021
Dosing regimen optimisation for oseltamivir in immunocompromised paediatric patients with influenza: Extrapolation of efficacy.
Journal: British journal of clinical pharmacology
Published: February 15, 2021
Bioanalytical aspects and challenges in supporting pediatric drug development.
Journal: Bioanalysis
Published: October 20, 2020
Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug-disease modelling for dosing regimen optimization.
Journal: British journal of clinical pharmacology
Published: February 12, 2020
Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission.
Journal: PLoS pathogens
Published: December 03, 2019
Mechanistic Population Pharmacokinetic Model of Oseltamivir and Oseltamivir Carboxylate Accounting for Physiological Changes to Predict Exposures in Neonates and Infants.
Journal: Clinical pharmacology and therapeutics
Published: October 10, 2019
Inconsistent internal standard response in LC-MS/MS bioanalysis: an evaluation of case studies.
Journal: Bioanalysis
Published: September 27, 2019
Determination of dalcetrapib by liquid chromatography-tandem mass spectrometry.
Journal: Journal of pharmaceutical and biomedical analysis
Published: January 23, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026